@dredmorbius @isagalaev @kravietz The presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781098/?report=reader